These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 4388711
1. [Therapeutic evaluation of a new antihistaminic: HS-592]. Guimarães NA, Fonseca O. Hospital (Rio J); 1968 Nov; 74(5):1511-4. PubMed ID: 4388711 [No Abstract] [Full Text] [Related]
2. [Clinical and allergological evaluation of Tavegil (HS-592), a new antihistaminic drug]. Bogdaszewska-Czabanowska, Starzycki Z. Przegl Dermatol; 1969 Nov; 56(5):659-65. PubMed ID: 4391299 [No Abstract] [Full Text] [Related]
11. [Experiences with Tavegil in dermatoses associated with pruritus]. Rothe A, Reichenhall B. Med Welt; 1972 Dec 02; 23(49):1876-7. PubMed ID: 4405207 [No Abstract] [Full Text] [Related]
12. [Clinical and experimental studies with the antihistaminic Tavegyl in dermatologic patients]. Grabner K. Wien Klin Wochenschr; 1970 Sep 04; 82(36):625-7. PubMed ID: 4396798 [No Abstract] [Full Text] [Related]
13. [Treatment of allergic skin diseases with hypostamin, with special regard to pruritus]. Andres HU, Krebs A. Praxis; 1968 Apr 16; 57(15):536-9. PubMed ID: 4388475 [No Abstract] [Full Text] [Related]
14. [Contribution to the clinical study of HS-592 in allergic manifestations]. da Rocha JM. Hospital (Rio J); 1969 Jan 16; 75(1):313-5. PubMed ID: 4387990 [No Abstract] [Full Text] [Related]
19. [Results of the use of a new synthetic antihistaminic (HS 592) in ophthalmology]. Laverone F. Ann Ottalmol Clin Ocul; 1968 Oct 16; 94(10):1217-24. PubMed ID: 4389858 [No Abstract] [Full Text] [Related]
20. [Clinical experience with a new antihistaminic]. Wolfram S. Wien Med Wochenschr; 1967 Sep 23; 117(38):868-70. PubMed ID: 4385553 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]